Skip to content
July 1, 2025
  • Fund blacklists def suppliers to Israeli army
  • Devin Booker in talks with Phoenix Suns on $150 million extension after career-best assist season
  • July New Rules: ప్రజలందరికీ బిగ్ అలర్ట్‌.. ఇవ్వాల్టి నుంచి మారనున్న రూల్స్ ఇవే..
  • Could Ozempic treat migraines? Popular obesity drug shows promise in a small study

Newsletter
Random News

Trending News

LATEST NEWS
Fund blacklists def suppliers to Israeli army 01
2 seconds ago
02
LATEST NEWS
Devin Booker in talks with Phoenix Suns on $150 million extension after career-best assist season
03
LATEST NEWS
July New Rules: ప్రజలందరికీ బిగ్ అలర్ట్‌.. ఇవ్వాల్టి నుంచి మారనున్న రూల్స్ ఇవే..
04
LATEST NEWS
Could Ozempic treat migraines? Popular obesity drug shows promise in a small study
05
LATEST NEWS
Andhra Pradesh: భక్తా.. బరితెగింపా.. శ్రీవారి ఆలయ నమూనాలో మిలటరీ హోటల్.. జనసేన నేతలు ఆగ్రహం..
06
LATEST NEWS
Libra Daily Health Horoscope Today, July 01, 2025: Check in with yourself before checking your phone
  • BREAKING NEWS
  • BUSINESS
  • EDUCATION
    • The Bharat Scouts And Guides
  • ENTERTAINMENT
  • HEALTH AND WELLNESS
  • LATEST NEWSYour blog category
  • TECHNOLOGY
  • SPORTS
  • Submit Your News
Live Now
Headlines
  • Fund blacklists def suppliers to Israeli army

    2 seconds ago
  • Devin Booker in talks with Phoenix Suns on $150 million extension after career-best assist season

    3 seconds ago
  • July New Rules: ప్రజలందరికీ బిగ్ అలర్ట్‌.. ఇవ్వాల్టి నుంచి మారనున్న రూల్స్ ఇవే..

    4 seconds ago
  • Could Ozempic treat migraines? Popular obesity drug shows promise in a small study

    6 seconds ago
  • Andhra Pradesh: భక్తా.. బరితెగింపా.. శ్రీవారి ఆలయ నమూనాలో మిలటరీ హోటల్.. జనసేన నేతలు ఆగ్రహం..

    6 seconds ago
  • Libra Daily Health Horoscope Today, July 01, 2025: Check in with yourself before checking your phone

    9 seconds ago
  • Home
  • BUSINESS
  • Canaccord Genuity Maintains a Buy on Inventiva (IVA) With a $20 Price Target

Categories

  • BREAKING NEWS
  • BUSINESS
  • EDUCATION
    • The Bharat Scouts And Guides
  • ENTERTAINMENT
  • HEALTH AND WELLNESS
  • LATEST NEWS
  • TECHNOLOGY
  • SPORTS
  • Submit Your News
  • BUSINESS

Canaccord Genuity Maintains a Buy on Inventiva (IVA) With a $20 Price Target

Sri Surya Drishti5 days ago01 mins
Follow
( 0 Followers )
X

Follow

E-mail : *

Post Content

​ 

News Views: 3

Post navigation

Previous: BofA Remains Bullish on Sana Biotechnology (SANA)
Next: BofA Reiterates a Buy Rating on Relay Therapeutics (RLAY), Sets a $17 PT

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Stock futures signal fresh highs as tax cuts advance in Senate while Trump balks at extending tariff deadline

Sri Surya Drishti21 hours ago 0

Top stocks to buy: Stock recommendations for the week starting June 30, 2025 – check list

Sri Surya Drishti21 hours ago 0

Mumbai urban push: Dharavi to get commercial business district; project eyes economic uplift, employment boost

Sri Surya Drishti21 hours ago 0

Asian markets show optimism: Stocks steady as US-Canada trade talks progress; eye on US jobs data due this week

Sri Surya Drishti21 hours ago 0

Recent Posts

  • Fund blacklists def suppliers to Israeli army
  • Devin Booker in talks with Phoenix Suns on $150 million extension after career-best assist season
  • July New Rules: ప్రజలందరికీ బిగ్ అలర్ట్‌.. ఇవ్వాల్టి నుంచి మారనున్న రూల్స్ ఇవే..
  • Could Ozempic treat migraines? Popular obesity drug shows promise in a small study
  • Andhra Pradesh: భక్తా.. బరితెగింపా.. శ్రీవారి ఆలయ నమూనాలో మిలటరీ హోటల్.. జనసేన నేతలు ఆగ్రహం..

Recent Comments

  1. P.v.sarvani on Dangeti Jahnavi: అంతరిక్షంలోకి అడుగుపెట్టబోతున్న తొలి భారతీయ మహిళ జాహ్నవి – మన తెలుగమ్మాయే

Archives

  • July 2025
  • June 2025

Useful Links

  • My account
  • Submit News
  • Subscription Management
    • Unsubscribe
  • News Letter
  • Privacy Policy
  • Contact Us

Copyright © 2025 | SRI SURYA DRISHTI | Developed, Hosted & Maintained by Sri Surya Techno Hub

Powered By BlazeThemes.